Development and evaluation of Alkanna tinctoria root extract and mupirocin nanoparticles-loaded porous films for the burn wound management
Document Type
Article
Publication Date
4-1-2026
Abstract
AbstractThis study aimed to fabricate and evaluate chitosan-polymethacrylic acid polyelectrolyte complex (CSPMA-PEC) porous films incorporating nanoparticles of Mupirocin and Alkanna tinctoria root extract for the management of burn wound. ATR-FTIR and differential scanning calorimetry (DSC) confirmed formulation component compatibility and thermal stability up to 150 °C. The CSPMA-PEC films exhibited a highly porous, interconnected structure (mean pore size 66 μm and 71.2% porosity), controlled biodegradation (42.3%) over 30 days, and suitable mechanical properties for handling and application (tensile strength 0.98 ± 0.3 MPa and % elongation 31.52 ± 2.1%). High swelling index (1275%) and water retention capacity (893.33%), indicated excellent hydrophilicity and moisture-holding capacity, supporting a moist wound environment and wound healing. In vitro studies demonstrated sustained release of Mupirocin and Alkanna tinctoria over a 24 h period, best described by the Korsmeyer-Peppas model (non-Fickian transport). Stability assessments under ICH guidelines showed no significant changes in drug content or its visual appearance. Dermal toxicity studies in rats revealed no evidence of irritation or systemic adverse effects. CSPMA-AT-MU-NPs films showed excellent antimicrobial activity against Staphylococcus aureus (33.57 ± 0.01 mm), Pseudomonas aeruginosa (33.78 ± 0.21 mm), Candida albicans (30.02 ± 0.13 mm) and Escherichia coli (26.17 ± 0.04 mm), compared to single-drug-loaded films. In vivo burn models in rats demonstrated accelerated wound contraction in the CSPMA-AT-MU-NPs film-treated animals compared with controls and silver sulfadiazine cream, confirmed by analyses showing improved collagen deposition, reduced inflammation and enhanced proliferation of fibroblasts. Overall, CSPMA-based porous films co-loaded with Alkanna tinctoria and Mupirocin nanoparticles represent a promising biocompatible platform for sustained drug delivery, robust antimicrobial effectiveness and tissue regeneration in burn wound management.
Keywords
Alkanna tinctoria, Burn wound, Chitosan, Mupirocin, Nanoparticles, Polymethacrylic acid, Porous film
Publication Title
International Journal of Biological Macromolecules
ISSN
0141-8130
DOI
10.1016/j.ijbiomac.2026.151783
Recommended Citation
Shah, Muhammad Khurshid Alam; Nawaz, Asif; Latif, Muhammad Shahid; Khan, Shakir Ullah; Mahsud, Kausar Ali; Alfatama, Mulham; Sofian, Zarif Mohamed; Nordin, Muhammad Luqman Bin; Alsaidan, Omar Awad; and Alzarea, Sami I., "Development and evaluation of Alkanna tinctoria root extract and mupirocin nanoparticles-loaded porous films for the burn wound management" (2026). Research Publications (2026 to 2030). 880.
https://knova.um.edu.my/research_publications_2026_2030/880
Volume
358
Publisher
Elsevier B.V.